News

Scient’x is relocating its US headquarters to West Chester, Pennsylvania from Maitland, Florida effective end of October 2008. The new, larger facility will house both the commercial and

Alcon has entered into a licensing agreement with GlaxoSmithKline (GSK) for global ophthalmic rights to cilomilast, a phosphodiesterase IV inhibitor. In addition to this new agreement, Alcon expanded

Mr Stevens has over 30 years experience in the medical device market, and has held top management positions with several spine companies over the last 15 years. Wolfgang

The allowed claims cover the use of veltuzumab and bispecific antibody protein constructs for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies and autoimmune diseases.

Mirixa Australia, a newly formed business venture, will be operated by the Guild’s healthlinks.net subsidiary. Under the agreement, Mirixa, which is sponsored by the National Community Pharmacists Association,

Tianyin has previously received the official approval from the Chinese State Food and Drug Administration (SFDA) to produce Azithromycin dispersible tablets in two dosage forms, 0.25gm and 0.1gm.

Mr Leng has been working for General Atlantic since 2007 and is based in China. Prior to joining General Atlantic, Mr Leng served as a managing director at

Part one was a randomized two-way crossover comparison study in 12 healthy subjects to test the pharmacokinetics, safety and tolerability of the original active pharmaceutical ingredient in capsule

Since January 2008, D’Agostino has been serving as Milestone’s acting CFO. Before joining Milestone, D’Agostino served as senior vice president and treasurer of Summit Global Logistics, a publicly